Donald Trump raised stakes in drug companies gaining from medicare exemptions, say Democrats

Economic Times - Oct 16, 2026

Investments in pharmaceutical companies on behalf of Donald Trump saw a significant increase after returning to the White House. His portfolio reportedly grew from $1.7 million in 2024 to as much as $56.2 million by late 2025. A large portion of this growth involved investing in stocks benefiting from exemptions to Medicare price negotiations. Notably, purchases included $2.55 million in shares just before signing favorable legislation.

Read full article
More News
Copyright © 2015 - 2026 The Financial Capital.

All Rights Reserved.

Subscribe Now!

About Us

The Financial Capital is your independent source for finance information and advice. We provide insights and offer advice from financial experts so you can make the best decisions.